GPG ME_Risk Minimisation II_Addendum_Draft_PC

First Page		Document Content
Date: 2015-04-14 08:59:35 Medicine Peptide hormones Recombinant proteins Diabetes Insulin Pen needles Diabetes management Insulin therapy Artificial pancreas Eli Lilly and Company Endocrine system Biology		GPG ME_Risk Minimisation II_Addendum_Draft_PC Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 188,55 KB Share Document on Facebook

	DOC Document DocID: 1xSLC - View Document
	PDF Document DocID: 1xt5X - View Document
	PDF Document DocID: 1xc40 - View Document
	PDF Document DocID: 1wA2I - View Document
	PDF Document DocID: 1wrFy - View Document